Literature DB >> 28396120

Klotho expression in osteocytes regulates bone metabolism and controls bone formation.

Hirotaka Komaba1, Jovana Kaludjerovic2, Dorothy Z Hu2, Kenichi Nagano2, Katsuhiko Amano2, Noriko Ide2, Tadatoshi Sato2, Michael J Densmore2, Jun-Ichi Hanai3, Hannes Olauson4, Teresita Bellido5, Tobias E Larsson4, Roland Baron2, Beate Lanske6.   

Abstract

Osteocytes within the mineralized bone matrix control bone remodeling by regulating osteoblast and osteoclast activity. Osteocytes express the aging suppressor Klotho, but the functional role of this protein in skeletal homeostasis is unknown. Here we identify Klotho expression in osteocytes as a potent regulator of bone formation and bone mass. Targeted deletion of Klotho from osteocytes led to a striking increase in bone formation and bone volume coupled with enhanced osteoblast activity, in sharp contrast to what is observed in Klotho hypomorphic (kl/kl) mice. Conversely, overexpression of Klotho in cultured osteoblastic cells inhibited mineralization and osteogenic activity during osteocyte differentiation. Further, the induction of chronic kidney disease with high-turnover renal osteodystrophy led to downregulation of Klotho in bone cells. This appeared to offset the skeletal impact of osteocyte-targeted Klotho deletion. Thus, our findings establish a key role of osteocyte-expressed Klotho in regulating bone metabolism and indicate a new mechanism by which osteocytes control bone formation.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGF23; bone; hyperparathyroidism

Mesh:

Substances:

Year:  2017        PMID: 28396120     DOI: 10.1016/j.kint.2017.02.014

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

3.  FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.

Authors:  L-C Desbiens; A Sidibé; R-V Ung; C Fortier; M Munger; Y-P Wang; S-K Bisson; K Marquis; M Agharazii; F Mac-Way
Journal:  Osteoporos Int       Date:  2018-06-29       Impact factor: 4.507

Review 4.  CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets.

Authors:  Rosilene Motta Elias; Maria Aparecida Dalboni; Ana Carolina E Coelho; Rosa M A Moysés
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

5.  FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.

Authors:  Zhousheng Xiao; Gwendalyn King; Salvatore Mancarella; Undral Munkhsaikhan; Li Cao; Chun Cai; Leigh Darryl Quarles
Journal:  JCI Insight       Date:  2019-12-05

Review 6.  Updates in CKD-Associated Osteoporosis.

Authors:  Pascale Khairallah; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 7.  Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions.

Authors:  L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

8.  Insulin suppresses the production of fibroblast growth factor 23 (FGF23).

Authors:  Ludmilla Bär; Martina Feger; Abul Fajol; Lars-Oliver Klotz; Shufei Zeng; Florian Lang; Berthold Hocher; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

9.  Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.

Authors:  B R Coyac; B Hoac; P Chafey; G Falgayrac; L Slimani; P S Rowe; G Penel; A Linglart; M D McKee; C Chaussain; C Bardet
Journal:  J Dent Res       Date:  2017-09-07       Impact factor: 6.116

Review 10.  Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Antoine Boulanger Piette; Dounia Hamoudi; Laetitia Marcadet; Françoise Morin; Anteneh Argaw; Leanne Ward; Jérôme Frenette
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.